Christopher J. Tovey, Chief Operating Officer at GW PHARMACEUTICALS PLC (GWPH), sold 1,200 shares at $15.01 ($18K) on 2019-05-15, disclosed to the SEC on 2019-05-17.
Scheduled sale ($18k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GWPH | SELL | 2019-06-05 | $947K | — | Filing → |
| GWPH | SELL | 2019-05-09 | $6.5M | — | Filing → |